|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | LC-01 |
| 用途 | 中间体 |
| 包装规格 | 20mg |
| 纯度 | 98%% |
| CAS编号 | 1195768-06-9 |
| 是否进口 | 否 |
联合知名大学科研院所及企业开发药食两用植物标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，小分子化合物库，药物杂质。所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。
Fields of Application :
Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.
| CAS Number: | 1195768-06-9 |
| Purity: | 99% |
| Molecular Weight: | 615.67 |
| Molecular Formula: | C24H24F3N5O5S3 |
Quality Control: HPLC、NMR、 LC/MS(Please contact us to get the QC report)
| Synonyms: | Dabrafenib Mesylate |
| Chemical Name: | |
| Storage: | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
Note: Products for research use only, not for human use
Description:
Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. Check For active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). For the detailed information about the solubility of Dabrafenib Mesylate (GSK-2118436B) in water, the solubility of Dabrafenib Mesylate (GSK-2118436B) in DMSO, the solubility of Dabrafenib Mesylate (GSK-2118436B) in PBS buffer, the animal experiment（test） of Dabrafenib Mesylate (GSK-2118436B),the in vivo,in vitro and clinical trial test of Dabrafenib Mesylate (GSK-2118436B),the cell experiment（test） of Dabrafenib Mesylate (GSK-2118436B),the IC50, EC50 and Affinity of Dabrafenib Mesylate (GSK-2118436B).
References:
C(S(NC1=CC=CC(C2=C(C3C=CN=C(N)N=3)SC(C(C)(C)C)=N2)=C1F)(=O)=O)1=C(F)C=CC=C1F.CS(O)(=O)=O
